Flaminia Pavone

USPTO Granted Patents = 7 (Patent Applications = 1)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 4.4

ph-index = 4

Forward Citations = 130(Granted Patents)

Company Filing History:

3 out of 7

Lay Line Genomics S.p.a.

patents

3 out of 312

Consiglio Nazionale Delle Ricerche

Years Active: 1989-2020

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10780149 - Therapeutic use of the botulinum neurotoxin serotype A (2020-09-22),

2. 9688749 - Molecules that are able to inhibit the binding between NGF and the TrkA receptor as analgesics with prolonged effect (2017-06-27),

3. 8715666 - Method for the potentiation of opioid analgesics effects on pain (2014-05-06),

4. 8691221 - Analgesic treatment with prolonged effect (2014-04-08),

5. 7988966 - Method for the potentiation of opioid analgesics effects on pain (2011-08-02),

6. 5306825 - Physostigmine derivatives with acetylcholinesterase inhibition (1994-04-26),

7. 4831155 - Physostigmine derivatives with acetylcholinesterase inhibition (1989-05-16),

Title: Flaminia Pavone: Innovator in Therapeutic Applications

Introduction

Flaminia Pavone is a distinguished inventor based in Rome, Italy. She has made significant contributions to the field of therapeutics, particularly in the use of botulinum neurotoxin and pain management. With a total of seven patents to her name, her work has the potential to impact many lives.

Latest Patents

One of her latest patents focuses on the therapeutic use of botulinum neurotoxin serotype A. This innovative application aims to treat paralysis caused by spinal cord injury. Another notable patent involves the use of an anti-NGF antibody that inhibits the binding between nerve growth factor (NGF) and the TrkA receptor. This development is significant for creating medications that treat and prevent chronic pain.

Career Highlights

Flaminia has worked with prominent organizations such as Lay Line Genomics S.p.a. and the National Research Council of Italy (Consiglio Nazionale Delle Ricerche). Her career reflects a commitment to advancing medical science through innovative research and development.

Collaborations

Throughout her career, Flaminia has collaborated with talented individuals, including Sara Marinelli and Gabriele Ugolini. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Flaminia Pavone stands out as an influential inventor in the field of therapeutics. Her innovative patents and collaborations highlight her dedication to improving medical treatments. Her work continues to pave the way for advancements in pain management and rehabilitation.

This text is generated by artificial intelligence and may not be accurate.